Transforming cardiovascular care through upfront combination therapy
2025-03-25
(Press-News.org) NEW ORLEANS - Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. “Chip” Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP). Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis explores the outcomes of combination lipid-lowering therapy (LLT) using statins and ezetimibe relative to statin monotherapy and could prevent thousands of deaths due to heart disease and stroke.
With a comprehensive evaluation of 14 studies encompassing over 108,000 high-risk individuals, the analysis reveals that the combination of statins with ezetimibe markedly lowers LDL cholesterol levels, achieving a mean reduction difference of -12.96 mg/dL and significantly diminishing the risk of all-cause mortality by 19%, major adverse cardiovascular events by 18%, and stroke incidence by 17%. The research underscores the comparable safety profile of combination LLT to statin monotherapy, with both approaches presenting similar risks of adverse effects and therapy discontinuation.
This pivotal study advocates for the integration of combination therapy early in treatment protocols, particularly for high and very high-risk groups. It highlights the potential for this integrative approach to not only meet LDL-C targets more effectively but also to substantially curtail mortality and CVD events.
Dr. Lavie stated, "The findings underscore the importance of a proactive, combination-based strategy in lipid-lowering therapy. By optimizing LDL-C reductions early, we can dramatically improve patient outcomes and reduce the global burden of cardiovascular disease."
The study authors encourage early intervention with combinations therapy in very high-risk patients, even before they suffer a cardiac event or stroke. By adopting a framework that includes upfront combination therapy, clinicians can enhance patient outcomes in the management of cardiovascular risks and diseases. This research represents significant progress toward optimizing prevention strategies and improving patient outcomes.
###
About Ochsner Health
Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for four consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and digital connectivity not found anywhere else in the region. In 2024, Ochsner Health cared for more than 1.6 million people from every state in the nation and 63 countries. Ochsner’s workforce includes more than 40,000 dedicated team members and over 4,900 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-03-25
Scientists from around the world specializing in motor control and neuroscience will travel to the University of Rhode Island this summer as the university hosts the international XV Progress in Motor Control Conference.
The university’s Department of Physical Therapy, its George & Anne Ryan Institute for Neuroscience, and the Interdisciplinary Neuroscience Program at URI, will host the biennial meeting of the International Society of Motor Control (ISMC) June 30 to July 2. This year’s conference will be held in the Center for ...
2025-03-25
LA JOLLA, CA—Zika virus and dengue virus are very close relatives. Both are mosquito-borne flaviviruses, and both specialize in infecting a host's dendritic cells.
But a new Nature Communications study, led by scientists at La Jolla Institute for Immunology (LJI) and UC San Diego shows that these two viruses have vastly different ways of making us sick.
Zika virus uses stealth. Zika virus slips into dendritic cells and blocks the dendritic cells from alerting nearby T cells to danger. It's the classic horror movie cliche—the creeper is already in the house, and ...
2025-03-25
MADISON — A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison.
The drug, called tofacitinib, also restores short-term and working memory lost to epilepsy in the mice and reduces inflammation in the brain caused by the disease. If the drug proves viable for human patients, it would be the first to provide lasting relief from seizures even after they stopped taking it.
“It ticks all the boxes ...
2025-03-25
SCAI Announces 2025-26 Recipients of JSCAI Editorial Fellowship Program
WASHINGTON — The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the selection of 10 outstanding early-career interventional cardiologists for the 2025-26 JSCAI Editorial Fellowship Program cohort.
The JSCAI Editorial Fellowship Program provides fellows-in-training and early-career interventionalists with a unique opportunity to develop their skills as peer reviewers and gain firsthand experience in the editorial process. Participants are paired with JSCAI Deputy or Associate ...
2025-03-25
For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled cell growth, cancer can emerge.
New CU Boulder research, published in the journal Science Advances, offers unprecedented insight into how an enigmatic enzyme, known as CDK7, drives this complex process. The research shows that novel cancer drugs designed to inhibit CDK7 can, within minutes, shut down gene expression pathways that drive cell proliferation in dozens of different ...
2025-03-25
New Haven, Conn. — Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into “cold” tumors and flip on an immune response that has been turned off by cancer. The research, published in Science Signaling on March 25, offers new findings that could help improve therapies for glioblastoma and other aggressive cancers that are difficult to treat.
“It turns out when this antibody gets into the cell’s cytoplasm [the liquid material inside the cell, excluding the nucleus] and it binds ...
2025-03-25
A flower-shaped structure only a few micrometres in size made of a nickel-iron alloy can concentrate and locally enhance magnetic fields. The size of the effect can be controlled by varying the geometry and number of 'petals'. This magnetic metamaterial developed by Dr Anna Palau's group at the Institut de Ciencia de Materials de Barcelona (ICMAB) in collaboration with her partners of the CHIST-ERA MetaMagIC project, has now been studied at BESSY II in collaboration with Dr Sergio Valencia. Such a device can be used to increase the sensitivity of magnetic sensors, to reduce the energy required for creating local magnetic fields, but also, at ...
2025-03-25
A new study explores how epigenetic markers—chemical modifications that influence gene activity—can help predict the risk of developing cardiometabolic diseases and guide personalized prevention strategies. The findings are particularly significant as the prevalence of major cardiometabolic risk factors such as hypertension, diabetes, and obesity continues to rise despite advancements in healthcare and treatment. This trend highlights the need for better early detection and intervention.
The study is titled “Poly-epigenetic scores for cardiometabolic risk factors interact with demographic factors and health behaviors in older US Adults” and is published in the journal ...
2025-03-25
The BBVA Foundation Frontiers of Knowledge Award in Basic Sciences has gone in this seventeenth edition to Avelino Corma (Institute of Chemical Technology, Universitat Politècnica de València-CSIC, Spain), John F. Hartwig (University of California, Berkeley, United States) and Helmut Schwarz (Technical University of Berlin, Germany) for fundamental advances in the catalysis field, in the words of the committee, that have made it possible to “control and accelerate chemical ...
2025-03-25
For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer’s disease and other chronic diseases. But these cells are also like needles in a haystack, difficult to identify by traditional scientific measures.
To find these problematic cells, a University of Illinois Chicago doctoral student has developed a powerful new software platform called SenePy. In a paper for Nature Communications, Mark ...
LAST 30 PRESS RELEASES:
[Press-News.org] Transforming cardiovascular care through upfront combination therapy
